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An exploration of aphasia therapy dosage in the first six
months of stroke recovery
Emily Brogan a,b*, Natalie Ciccone a* and Erin Godecke a,b*
aSchool of Medical and Health Sciences, Edith Cowan University, Perth, Australia; bSpeech Pathology,
Sir Charles Gairdner Hospital, Perth, Australia
ABSTRACT
Aphasia research uses the length of time within rehabilitation
sessions as the main measure of dosage. Few papers detail
therapeutic ingredients or outline the number of times these
were delivered over the treatment period. The present
observational study identified therapeutic ingredients in the
Very Early Rehabiltiation in SpEech (VERSE) trial and explored
the dosage provided using a model of cumulative
intervention intensity (CII). Therapists video recorded one
therapy session per week and 53 (12%) randomly selected
therapy videos were analysed. The videos were coded for
number of error productions, self-corrections and type and
frequency of therapist cueing. The Western Aphasia Battery
Revised-Aphasia Quotient (WABR-AQ) was used for measuring
patient outcome with total verbal utterances (p < 0.001) and
cues used with success (p < 0.001) being independent positive
predictors of WABR-AQ score at six months post stroke and
hypothesized as key therapeutic ingredients. The CII was
calculated by counting identified therapeutic ingredients and
multiplying this by the number of sessions completed.
Collectively, the key ingredients occurred on average 504
times per session and over 10,000 times per participant during
the treatment period. This paper reports a novel approach for
identifying key treatment ingredients and detailing the
dosage delivered within an early aphasia rehabilitation trial.
ARTICLE HISTORY
Received 6 September 2019






The rehabilitating brain and dosage
Rehabilitation has progressed froma focus on rheumatic diseases in the nineteenth
century, through war time needs, to the present day. More people are surviving
brain injury than ever before, resulting in greater demands placed on rehabilitation
services (van de Sandt-Koenderman et al., 2012). For rehabilitation to be successful,
© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives
License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction
in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
CONTACT Emily Brogan e.brogan@ecu.edu.au https://www.researchgate.net/profile/Emily_Brogan2
http://www.linkedin.com/in/emily-riseley-193680109 Edith Cowan University, 270 Joondalup Drive, Joondalup,
Perth, Western Australia 6027, Australia @embrogan89
*Present address: Aphasia Centre for Research Excellence, La Trobe University, Melbourne, Australia
NEUROPSYCHOLOGICAL REHABILITATION
https://doi.org/10.1080/09602011.2020.1776135
the brain relies on complex chemical and neuronal mechanisms to induce perma-
nent adaptation in cognitive processes. Learning is a cognitive process essential to
successful rehabilitation. Behavioural therapy for impairmentsafter abrain lesiondo
not aim to provide a cure but tomaximize the capacity of the damagednetworks to
re-learnwithexperienceand for learning toalter theneural functioningat a synaptic
level (Murphy & Corbett, 2009; Varley, 2011). Identifying the optimal treatment and
its dosage is highly complex given the myriad of factors that may influence the
effect of treatment (Kamhi, 2012). Important components of the rehabilitation
jigsaw may include dosage, therapeutic relationship, medium of therapy delivery,
client motivation, cognitive ability, neurological stability (Whitworth et al., 2014)
as well as task-specific practice (Lang et al., 2015). Developing an understanding
of the key elements of therapy needed and the dosage with which these should
be delivered are likely to be an important piece of the rehabilitation jigsaw.
Learning within neurorehabilitation sessions is concerned both with client acts
and inputs from the therapist (Kleim & Jones, 2008). The dosage at which these
are delivered is crucial. Treatment sessions aim to capitalize on and enhance the
brain’s natural inherent plasticity that underpins learning (Crosson et al., 2019). Neu-
rorehabilitation focuses largelyonpracticedependent learning that occurswhenan
individual repeatedly uses a skill to induce lasting neuronal change (Robbins et al.,
2008). This focus is grounded largely in Hebbian learning theory which proposes
learning occurs by connections that develop through inputs that co-occur and
can be summarized by “neurons that fire together wire together” (Hebb, 1949). It
requires repetition to induce lasting cellular changes that add stability to the
network (Pulvermuller & Berthier, 2008). Neuronal assemblies must be repeatedly
active at the same time when forming links (Pulvermuller & Berthier, 2008).
Increased repetition of a newly learned behaviour may be required to induce
lasting neural changes (Kleim & Jones, 2008) and so, in theory, the more frequently
two relevant brain events occur together, the more the critical connections will be
strengthened (Pulvermuller & Berthier, 2008). Assuming that therapy can induce
coincidental learning, it has been hypothesized that more training will help
improve learning and may change behaviour (Pulvermuller & Berthier, 2008). It is
also hypothesized that there is a point of diminishing return to increasing the
amount of therapy and so the dosage associated with a therapeutic “sweet spot”
is yet to be discovered (Yoder et al., 2012). Additionally, there is the term “reaction
range” indicating that the response to therapy varies depending on the individuals
brain functioning (Gottesman, 1963; Yoder et al., 2012). Bothof these conceptsneed
to be considered in neurorehabilitation as increasingly, particularly with aphasia
therapy, intense may not be better (Godecke et al., 2018).
Defining dosage
There is no consensus for a definition of dosage within the stroke rehabilitation lit-
erature. Dosage has been defined as the amount of the active ingredient delivered
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at any one time, the frequency with which the active ingredient is delivered and
time duration or length of time across which the active ingredient needs to be deliv-
ered in order to produce the desired effect (Lang et al., 2015). Frequently, in the
stroke rehabilitation literature, the terms intensity and dosage are used interchange-
ably. There has been a call for consistent distinct terminology as the terms intensity
and dosage have been used to refer to a greater number of therapeutic events
occurring in a shorter amount of time, greater number of hours in therapy
massed or distributed, or a greater number of total hours of therapy (Harnish
et al., 2014). Definitions of dosage vary in the physical therapy literature with
some defining dose as the amount of time actively spent in practice and others
as the number of repetitions of amovement. However, the concept of repeated epi-
sodes of intervention over a period of time is common across the different
definitions of dosage (Baker, 2012). In a meta-analysis of dose–response relation-
ships in stroke rehabilitation, the dosage measure of therapy time was used as
this was the most consistently reported measure in studies (Lohse et al., 2014).
The authors acknowledged that ideally active time in movement practice or move-
ment repetitions would be reported and used in subsequent meta-analyses.
Although the measurement of limb movements or repetitions is different to the
measurement of repetition in language based activities, the same challenges associ-
atedwithmeasuring dosage are present. This paper uses the definitions of dose and
intensity outlined by Warren et al. (2007) which is explained further. Regardless of
how dosage is defined, increasing the dose of rehabilitation interventions is a
major challenge for therapists (Vratsistas-Curto et al., 2019). Computerized or tech-
nology-based therapies have the potential to support increasing the dose of therapy
as patients may practice independent of the therapist and be set dose targets to
attain. There may be additional benefits to computerized therapies such as obtain-
ing data on dose and practice fidelity without relying on therapist report or moni-
toring therapist participant interactions.
Measuring dosage
The measurement of dosage is complex in behavioural interventions however
needs to be considered in planning and monitoring interventions. In planning
an intervention it is not only important for researchers to specify a therapy type
but also whether an intended level of dosage (amount in the session) is a key com-
ponent of the therapy. In the implementation of the intervention the level of
dosage provided should be measured and then reported within publications.
These processes are needed in order to develop a greater understanding of the
impact of the dosage within the interventions being trialled. Despite the complex-
ity in measuring dosage it is vitally important to make sure the minimum required
dosage level is planned for and achieved in treatment efficacy research. Specifying
dosage will allow for improved treatment fidelity, facilitate the completion of repli-
cation studies and better therapy delivery to patients (Harnish et al., 2014). As an
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example, Bakheit et al. (2007) reported that only thirteen of the fifty one partici-
pants received the intensive aphasia intervention as planned. The study cited
that it was likely the amount of therapy received by the intensive therapy group
was below the threshold that is required to significantly enhance recovery of
language function (Bakheit et al., 2007; Robey, 1998).
A formula for dosage
While it is acknowledged that is important to measure the dosage of an interven-
tion, a definition of dosage and a method of measuring dose is not yet well
accepted. Warren et al. (2007) called for behavioural scientists to adopt a
similar approach to the pharmacological studies and investigate therapeutic
effects for different dosage levels. They proposed a comprehensive model of
intervention intensity and this was adapted and applied by Baker (2012). The
model provides a method of determining the dose of a treatment, or the Cumu-
lative Intervention Intensity (CII), across an intervention period by first consider-
ing the task in which the teaching episode takes place. In the CII formula the
focus is shifted from session duration to the number of times an ingredient
occurs per session. Session duration in minutes is only considered when measur-
ing a dose rate (Dose/session duration (mins)). The concept has been praised for
encouraging researchers to develop a quantitative model of interactive factors to
describe a treatment approach. Figure 1 outlines Baker’s (2012) application of
Warren et al. (2007) dosage concepts visually.
Parameters involved in determining the optimal intensity of intervention,
based on Warren et al. (2007).
The application of most of these parameters appears straight forward for
aphasia research. However, even the simplest treatments are multifaceted
(Warren et al., 2007) and identifying the teaching episodes that contain the
active ingredients is the most difficult aspect of implementation. It is unclear
which factors contribute to cumulative intervention intensity and whether these
will influence treatment outcome in aphasia (Crosson et al., 2019). Even a
picture naming task in therapy involves many cognitive processes that could
contain a number of active ingredients such as the cueing or feedback used by
the therapist, and whether the task is at the correct challenge point for the
people with aphasia (PWA). There is the additional complexity of whether the
accuracy of production counts or discounts a teaching episode. For example, an
error made during stimulus production may exclude that attempt in the dosage
calculation, depending on the underlying theory of the treatment. Warren et al.
(2007) suggest that this is one of the benefits of the model in that it requires clin-
icians and researchers to think about and specify what their active ingredients are
as well as the theory underpinning them. More broadly, researchers need to con-
sider whether interventions could be examined to identify the active ingredient/s
in order to measure these and prescribe a dose (Baker, 2012).
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Active ingredients in aphasia therapy
Behavioural interventions are thought to have one or more active ingredients.
Articles about complex treatments often don’t provide information on active
ingredients (Behn et al., 2019; Ludemann et al., 2017; Yamato et al., 2016) or
their corresponding dosage because it hasn’t been investigated, possibly due
to the challenges associated with measuring these components (Cherney,
2012). Aphasia and other complex interventions can be viewed as a “black
box” containing therapeutic inputs and clients’ outputs with little understanding
of how the components of therapy work. Dissecting the “black box” of treat-
ments, in order to identify the active ingredients and explain how they work,
is a challenge for researchers and practitioners. One explanation for why we
lack more detailed understandings of therapies is that rehabilitation practice is
frequently not theory driven (Dijkers et al., 2014). If researchers were able to dis-
aggregate interventions to test theory driven hypotheses about potential active
Figure 1. Reproduced with permission from Baker (2012).
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ingredients we may have more knowledge about the individual and joint effects
of our treatments not just whether they work or not (Dijkers et al., 2014).
When the targeted goals are complex, defining teaching episodes becomes
very challenging (Hoffman, 2009). Baker (2012) has highlighted that dosage can
only be determined accurately when active ingredients within teaching episodes
have been identified. In doing this it is important to consider how the underlying
theory is applied in the development of the treatment. For example, neuroplasti-
city principles state that accurate, error-free practice of a skill is beneficial for reha-
bilitation outcomes (Biernaskie & Corbett, 2001; Nudo, 2013; Raymer et al., 2008).
Therefore, investigations of therapy may focus on the quantity and accuracy of
language produced by PWA. The rationale for examining how much PWA say is
that (a) improvement in therapy is experience dependent and (b) a lack of experi-
ence of practice may result in learned non-use (Pulvermuller et al., 2001; Pulver-
muller & Berthier, 2008). Therapy should involve practising tasks, involving an
error minimization approach, to avoid a lack of experience causing atrophy in
the network as well avoiding the strengthening of negative neural networks
(Varley, 2011). If recovery depends both on the quantity and accuracy of PWA pro-
duction then therapist behaviours, including cueing to facilitate successful outputs
from the PWA, together with the PWA’s production or output within therapy, are
key to recovery. This is in line with Baker’s (2012) view that active ingredients can
involve therapeutic inputs or client acts.
Aphasia rehabilitation and dosage
According to the most recent Cochrane review, speech therapy is beneficial for
people with aphasia (Brady et al., 2016). However, there is a dearth of literature
on the optimal intervention intensity and the dose with which intervention
should be delivered (Baker, 2012; Off et al., 2016). As such, the optimal treatment
regimen in aphasia rehabilitation is unknown (Dignamet al., 2015). Despite theexist-
ence of definitions for intensity and dosage (Baker, 2012; Warren et al., 2007), oper-
ational definitions of treatment intensity and dosage have not been agreed upon
and are not applied consistently within aphasia research. Additionally, when time
in therapy is used as a definition on treatment intensity and/ or dosage, there is
inconsistency in the description of what constitutes high and low dose therapy pro-
vision. For example dosage is described, within the Cochrane review (Brady et al.,
2016), as hours of therapy provided reflecting theway inwhichdosage ismost com-
monly reported in studies in the review. The number of therapy hours in the “high
dose” speech language pathology (SLP) intervention varied from twenty seven
hours up to 208 hwhereas “low dose” received five hours to 78 h. The inconsistency
in terminology presents a challenge for researchers and clinicians.
When intensity has been investigated as a key factor in the outcome of
therapy it is unclear if the impact of therapy is due to the intensity with which
the therapy was provided or what was contained within the therapy (Sage
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et al., 2011). While many aphasia studies, as per the Cochrane review, report
intervention dosage using time, they give little insight into active ingredients
or within session therapy dosage. When Cherney (2012) compared eleven
studies across 195 participants for high and low intensity aphasia they found
that only 3 studies provided information on the dosage level delivered within
the session, or the number of times a teaching episode containing an active
ingredient occurred per session. It is not only that intervention studies are not
reporting optimal intensity, but the dosage of a “typical” aphasia therapy
session is also unknown as benchmarking studies are rarely undertaken
(Enderby, 2012). This means many therapists are therefore unaware of the
dosage they are providing in usual care, or the active ingredients of the
therapy, so it is also important to establish normative data prior to dosage
manipulation (Dignam et al., 2015).
Efforts havebeenmademore recently to specify key therapeutic ingredients and
report the dosage of these within trials. Dignam et al. (2015) provided the cumulat-
ive treatment intensity as per Warren et al.’s (2007) model for the treatment deliv-
ered in thefirst dosage controlled, parallel-groupdesign study to compare the short
and long term therapeutic outcomes of massed versus distributed comprehensive
aphasia programme in participants with chronic aphasia. Distributed over massed
practicewas favoured inwhich therapy in thedistributed arm involved6hperweek
for 8weeksdayswhereasparticipants in the intensivepracticearmreceived16hper
week for 3 weeks. All participants received Aphasia LIFT therapy (Rodriguez et al.,
2013), a combination of impairment, functional, computer based and group
therapy. Over the treatment period the semantic feature analysis component deliv-
ered 118.3 teaching episodes and the phonological component analysis delivered
114.3 teaching episodes. This represents a high level of dosage analysis for an
aphasia trial. Another attempt at measuring the dosage of active ingredients is a
case series study fromHarnish et al. (2014) who used a targeted cueing programme
for aphasia rehabilitation. Eight participants attempted toname fifty target pictures,
eight times during each session for a total of 400 attempts per session. The reported
cumulative intervention intensity was 3200 teaching episodes and the treatment
resulted in significant gains in reacquiring problematic words (Harnish et al.,
2014). This study has been praised for its well-constructed theory driven protocol
that provides the foundation for continued and deliberate dosage investigations
(Off et al., 2016). It is plausibly easier to conceptualize measuring dosage in single
word treatments as opposed to conversational treatments and this presents a chal-
lenge for discourse rehabilitation.
Study aims
This study investigated the dose form and dose frequency (Warren et al., 2007)
provided within the Very Early Rehabilitation in SpEech (VERSE) trial (Godecke
et al., 2016) sessions with the following aims:
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(i) Analyse the dosage level provided within a session for:
a. The two intensive therapy groups (Usual Care-Plus and VERSE)
b. Aphasia severities (mild, moderate and severe)
(ii) Identify key ingredients in the intervention that are correlated with the
primary outcome at 12 and 26 weeks post stroke.
(iii) Calculate the cumulative intervention intensity for both intensive therapy
groups (Usual Care-Plus and VERSE) (Warren et al., 2007).
Method
Very Early Rehabilitation in SpEech (VERSE) Trial
VERSE investigated whether intensive prescribed aphasia therapy (VERSE treat-
ment) and intensive non-prescribed usual care therapy were more effective
and cost saving than non-prescribed usual care training in very early aphasia
recovery after stroke (Godecke et al., 2013). VERSE was a RCT with the interven-
tions offered in the trial as follows:
(i) Usual Care: Participants randomized to this group received care that is
typical for aphasia management and at the discretion of the treating SLP.
It also included management of other speech pathology impairments
such as dysphagia, dysarthria and/or apraxia of speech however only
aphasia specific hours were included as therapy hours within the primary
study analysis.
(ii) Usual Care-Plus: Participants received treatments typical of direct aphasia
therapy, at the discretion of the treating SLP, but with a defined therapy
regimen of daily (5 days per week) aphasia therapy sessions for 45–60
min duration over 20 sessions. Direct aphasia therapy included 1:1 impair-
ment based therapy, impairment based computer training, social training,
group impairment based therapy, group social training or Augmentative
and Alternative Communication (AAC) training. As the Usual Care-Plus con-
dition in the trial did not include a prescribed treatment type, specified
active ingredients or dosage schedule, there is a unique opportunity for
measurement of a “typical” aphasia session.
(iii) VERSE intervention: The intensity of this intervention armmatched that of the
Usual Care Plus arm but the intervention was prescribed and standardized
according to a VERSE intervention protocol. As per treatment fidelity rec-
ommendations, significant consideration was given when planning the pre-
scribed intervention to highlight theoretical underpinnings, allowing these to
be monitored and evaluated. The goal of the VERSE prescribed treatment,
was to facilitate and improve verbal output with therapists using a targeted
cueing hierarchy to promote successful, independent verbal production.
Therapists were instructed to use cues that were most likely to be successful
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once participants produced an incorrect response. Participants were encour-
aged to repeat the target for practice in connected speech. The rationale
behind the treatment postulated that correct production of the target as
quickly as possible would strengthen the networks responsible for language
production and that high repetition of output with reduced error production
would lay the foundations for improved language and communication out-
comes in early stroke recovery. In this way, cueing was thought to be a
key ingredient as well as the dosage level of error free productions achieved
by the participant in a session.This impairment based intervention was
founded on principles of promoting neuroplasticity through targeted early
intensive language therapy. The main principles that guided the VERSE pre-
scribed intervention were (a) massed practice (b) error-free learning (c) task
complexity (d) salience and (e) maximizing communicative success
through interactive functional tasks.
Participants
Participants were recruited to VERSE if they had aphasia secondary to an acute
intracerebral haemorrhage or ischaemic stroke, were 18 years of age or over,
had corrected hearing and vision, were medically stable at or before 14 days
post stroke and could participate in aphasia therapy in English without the
need for an interpreter. Exclusion criteria included pre-existing aphasia prior to
hospital admission, a history of progressive neurological disease, brain injury,
neurosurgery or major depression, and an inability to maintain alertness for 30
consecutive minutes at 14 days post stroke. Following baseline assessment, par-
ticipants were randomized using a computer-generated, block randomization
sequence, stratified for aphasia severity via the REDCAP web-based programme
(Harris et al., 2009). VERSE recruited 246 participants, 81 in usual care, 82 in Usual
Care-Plus and 83 in the VERSE condition (Usual Care-Plus and VERSE conditions
being the intensive conditions). Participants were recruited from sites across Aus-
tralia and New Zealand and were assessed at baseline, 12 and 26 weeks post
stroke on a range of impairment, psychosocial and economic based measures.
The primary outcome measure and dependent variable for VERSE was the
WAB-AQ (Kertesz, 2006) at 12 weeks post stroke. Please refer to the VERSE pro-
tocol paper (Godecke et al., 2016) for full study details. Recruitment was com-
pleted in February 2018 and the last patient visit was undertaken in August 2018.
Therapists
In the UC+ and VERSE conditions SLPs were contracted specifically for the trial
and were qualified SLPs. All UC, UC+ and VERSE treating SLPs underwent training
(five hours) and received procedural and training manuals relevant to the arm of
therapy they were providing. Clinical support was provided by the trial Treat-
ment Fidelity Coordinator (VERSE) or trial clinical staff as required.
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Therapy fidelity dosage sub-study
Video recording and randomization
This study examined therapy videos collected from the VERSE and UC+ arms of
the VERSE trial (Godecke et al., 2016). Therapists from the two intensive therapy
arms VERSE and UC+ were required to record four therapy sessions over the 20
sessions completed. Therapists were encouraged to record one session a week.
Of the 246 participants included in the VERSE trial (81 in UC, 82 in UC+ and 83 in
the VERSE condition), 434 therapy videos were recorded (5% of the 8915 therapy
sessions completed in the trial). To be included in the current study videos had to
be at least forty minutes in length and not contain the present author as the
therapist, the participants shown in the video had to have completed the full
treatment protocol and have the 12 and 26 week dependent outcome
measure score, WABR-AQ (Kertesz, 2006) available and the video needed to be
playable on Windows Media Player. A research assistant not involved with the
current project used a computer generated block randomization sample of
videos stratified for aphasia severity to select therapy videos for all participants.
The sample comprised 53 randomly selected videos representing 12% of the
total recorded sample.
Procedure
Transcription. The selected videos were transferred and stored in a secure cloud
based service. Each therapy video was then transcribed verbatim using transcrip-
tion conventions as outlined in the Systematic Analysis of Language Transcripts
(SALT) Transcription guidelines and software (Miller, 2008) (available at http://
saltsoftware.com/resources/tranaids). This included segmenting utterances in
Communication Units or C-Units. Each transcription was then coded according
to a pre-determined set of measures that were based on the theoretical con-
struct of the intervention and believed to represent key therapeutic ingredients.
Coding. Word and utterance level codes, related to the aims of this research,
were developed. Of particular note were the number of error free utterances
and utterances containing errors. The investigation of client acts in this study
focused on the quantity and accuracy of speech from PWA and was grounded
in a neuroscience perspective of experience dependent plasticity, learned non-
use and Hebbian theory (Hebb, 1949; Pulvermuller & Berthier, 2008; Varley,
2011). Aphasia treatment approaches are often described as “error full” or
“error free” referring to whether the PWA is encouraged to attempt target attain-
ment irrespective of the error quantity or whether errors are minimized to avoid
strengthening of associated negative neural networks. For this reason the pro-
duction and management of errors and participant self-correction of errors
was an area of focus within the coding with frequency of errors and self-correc-
tions viewed as potential active ingredients.
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An error free response was defined as one which was “appropriate and accu-
rate for the context and not corrected or modified by the therapist”. Frequently, the
stimulus materials were visible in the therapy video and the transcriber was able
to evaluate the response. In the event that the response could not be assessed as
correct by the video reviewer, it was defined as a response that did not receive
correction or negative feedback from the therapist. Error free responses were
coded at the C-unit/ utterance level. Errors were defined as “inaccurate pro-
ductions at the word or sentence level that required modification, correction or
negative feedback from the therapist”. Error responses were marked at the
word level and utterance level and utterances could contain multiple errors. If
an error was corrected by the PWA, without intervention from the therapist, it
was coded as a self-correction with the initial mistake coded as an error. Bound-
aries of therapy tasks were not always clear and social conversation was often a
target of therapy. Therefore every utterance from the participant within the
therapy session, from the beginning to the end of the session, was coded and
used as a measure of dosage. Table 1 outlines the codes used in transcription.
Transcription analysis
Dose form. The dosage delivered within a session is highly dependent on the
type of therapy task, or dose form (Warren et al., 2007) being used. A task was
judged by the primary author while watching the videos and was defined as
the medium through which therapy was taking place and reflective of a
specific therapy goal. For example, picture naming at the single word level
would reflect a task. The same stimuli used in a sequence to generate sentences
would reflect a new task. Tasks usually contained stimuli and task explanations
although not always. Most sessions contained multiple tasks and many tasks
were seen multiple times in the therapy videos. The total number of different
tasks provides a value for the number of times therapists used a task that was
unique i.e., had not been used by any other therapists in the videos.
Session duration. Dosage is also dependent on the duration, or length of a
session. To calculate the dosage rate of active ingredients (Dose/session duration
(mins)) the session duration is needed (Warren et al., 2007). Session duration was
Table 1. Dosage related measures and possible active ingredients.
Measure Definition
Error free utterances Total number of utterances without an error.
Errors Total number of errors produced.
Non-verbal
responses
Responses that are non-verbal (e.g., gestures).
Self-Corrections Errors that have been self-corrected prior to intervention from the therapist
Cues used with
success*
The number of times a cue was used by the therapist and the participant responded
correctly following the cue.
Note: *Cues used with success may represent a client act or therapist input. For ease of interpretation, it has been
categorized as a therapist input within this paper.
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controlled for in the VERSE study as sessions had to be greater than forty minutes
in length and twenty sessions were given in total. The session duration for the
specific 53 videos used in this study is reported. Please note that session duration
and dosage rate are reported however they are not used in the formula for the
CII (dose × dose frequency × total intervention duration).
Dose. Following transcription and coding, calculations were performed by the
SALT software for both the participant and therapist utterances. These were
total number of verbal utterances, mean length of utterance (MLU) in words
and morphemes, total words, words per minute (WPM), utterances per minute
(UPM) and mean turn length in words. In addition, calculations based on the
codes error codes outlined previously were made manually and these formulas
can be seen in Table 2. Counts of the codes and the calculations were entered
into the statistical software programme SPSS (IBM Corp, 2015) together with
demographic data and the WABR-AQ scores at 12 and 26 week post stroke
scores (dependent measures).
Statistical analysis
Descriptive statistics are presented for participant, session number and duration,
recovery and dose form data. A Welch’s t-test for unequal variances with p >
0.001 (as per Bonferroni correction) was performed to establish significant differ-
ences in dose. Within VERSE and Usual Care-Plus arms of the VERSE trial sessions
were expected to be at least 45 min long. However as session time was not con-
trolled for exactly, session length usually ranged from 45 to 60 min, longer
therapy sessions would naturally be higher in many measures. These measures
(as per Tables 8 and 9) were adjusted by dividing the total by the session
time. The resulting standardized data was used in the statistical analyses.
Descriptive statistics are presented according to therapeutic group and




The number of utterances verbally generated spontaneously. e.g., not a repetition
of a model or a gesture. (verbal utterances) – (repetitions + gestures)
Utterance Level Errors Total number of errors that occurred at the utterance level.
Word Level Errors Total number of errors that occurred at the word level.
% errors self-corrected (self-corrections) / (total errors) x 100
Average no. of errors per
utterance
(verbal errors) / (verbal utterances)
Average no. of utterances
per error
(verbal utterances) / (verbal errors)
% total words with errors (errors) / (total words) x 100
Total Turns (participant) Total utterances
Verbal utterances
(participant)
Total utterances – gestures
Total number of cues used Total number of cues used by the therapist.
% Cues that were successful Percentage of the total number of cues used by the therapist that were successful
in facilitating accurate production.
Total therapist utterances Total utterances produced by the therapist.
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aphasia severity is in unadjusted raw format to maintain context. An ANOVA was
used for the between group analyses, to examine differences between therapy
group (UC+ and VERSE) and aphasia severity (mild, moderate, severe). Signifi-
cance set at p < 0.05 for post hoc analyses.
A linear regression was used to explore the relationship between potential
therapy active ingredients, considering and client acts and therapeutic inputs.
A linear regression model was used across both therapy groups (VERSE and
Usual Care-Plus) with the participant’s primary outcome measure, their WABR-
AQ score at 12 and 26 weeks being the dependent measure. The WABR-AQ
score at 26 weeks was used as we wanted measures to show longer term associ-
ation with the dependent variable to be suggestive of maintenance. A Bonferroni
correction was used for multiple comparisons according to the number of vari-
ables in the analysis and significance was set at p < 0.00277. Baseline aphasia
severity as per the WABR-AQ and the overall amount of direct aphasia therapy
was included as predictors in the model to account for these factors. To be ident-
ified as predictive of WABR-AQ score at 26 weeks, measures had to be significant
at 26 weeks post stroke, demonstrating longer term association. The identified
ingredients were used to calculate the cumulative intervention intensity [dose
(client acts and therapist inputs) × dose frequency × total intervention duration]
(Warren et al., 2007).
Reliability
Six videos (one from each of the three aphasia severity groupings in UC+ and
VERSE) were re-coded for inter and intra-rater reliability by another SLP trained
in the coding methods for this study. This comprised 11% of the total sample
in this study. Reliability was established using the intra-class correlation coeffi-
cient (ICC) in SPSS (IBM Corp, 2015) with a consistency 2-way mixed effects
model. The ICC was established on the four key coded measures of interest in
the study – error free utterances, total errors made, total self-corrections and
the total number of cues used with success by the therapist. Koo and Li’s
(2016) guidelines for reporting the ICC have been adhered to in the tables
below. As per Table 3, three of the measures had ICCs in excess of 0.90 and there-
fore, inter-rater reliability is reported as excellent. The self-corrections measure
was lower with ICCs in the range of 0.75–0.90 which remain in the good reliability
range (Koo & Li, 2016). As the ICCs were all in excess of 0.90 as per Table 4, intra-
reliability is reported excellent.
Table 3. Inter-rater reliability results using ICC calculation.
Code Intraclass Correlation
95% Confidence Interval F Test With True Value 0
Lower Bound Upper Bound Value df1 df2 Sig
Error free .99 .95 .99 273.75 5 5 .000
Errors .95 .69 .99 38.37 5 5 .001
Self-corrections .81 .13 .97 9.35 5 5 .014




The 53 videos presented therapy sessions of 44 different participants. This
comprised 27% of the total number of participants included in the intensive
arms of the trial (UC+ and VERSE, 165 participants). Of the 53 videos selected
through randomization seven participants had two videos in the sample (total
14 videos), one participant had three videos in the sample (total 3 videos) and
the remaining 36 participants had one video each (total 36 videos). This
resulted in the inclusion of 44 different participants. Table 5 presents the
demographic details of these participants. Twenty-five different SLPs were
included within the analysed videos.
Session number
Figure 2 displays the most frequently analysed session numbers within this
sample. Session number fourteen, twenty and five were the most frequently
viewed.
Table 4. Intra-rater reliability results using ICC calculation.
Code Intraclass Correlation
95% Confidence Interval F Test With True Value 0
Lower Bound Upper Bound Value df1 df2 Sig
Error free .99 .95 .99 281.24 5 5 .000
Errors .99 .92 .99 162.17 5 5 .000
Self-corrections .99 .95 .99 270.62 5 5 .000
Successful Cues .99 .95 .99 300.42 5 5 .000
Table 5. Participant demographic and stroke characteristics.
Demographic Whole group (n = 44)* VERSE (n = 25) Usual Care-Plus (n = 19)
Age, Mean (SD) 72.0 (14.8) 75.0 (14.2) 68.0 (14.7)
Female, n (%) 19 (43) 12 (48) 7 (37)
Oxford Stroke Classification
Haemorrhagic, n (%) 3 (7) 2 (8) 1 (5)
PACS, n (%) 34 (77) 18 (72) 16 (84)
PoCS, n (%) 1 (2) 0 (0) 1 (5)
TACS, n (%) 6 (14) 5 (20) 1 (5)
Baseline WAB AQ Severity
Mild, n (%) 15 (34) 8 (32) 7 (37)
Moderate, n (%) 13 (30) 7 (28) 6 (32)
Severe, n (%) 16 (36) 10 (40) 6 (32)
Modified Rankin Scale Score
2 – Slight, n (%) 6 (14) 5 (20) 1 (5)
3 – Moderate, n (%) 17 (39) 7 (28) 10 (53)
4 – Moderate Severe, n (%) 11 (25) 7 (28) 4 (21)
5 – Severe, n (%) 10 (23) 6 (24) 4 (21)
National Institutes of Health Scale Score
Mean (SD) 9.1 (7.1) 9.4 (7.5) 8.7 (6.5)
Note: PACS = partial anterior circulation syndrome; PoCs = posterior circulation infarct; TACs = total anterior circu-
lation infarct. Baseline WAB-AQ Severity Scores = mild (>62.6), moderate (32.3-62.5) and severe (0-32.2).
*53 videos were selected through randomization. Eight participants had more than one video and 36 participants
had one video in the sample. Therefore, 44 different participants are included in this sample.
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Recovery
Figure 3 provides an overall context to the recovery of the participants included
in this study. Based on their severity diagnosis at baseline and reassessment at 12
and 26 weeks on the WABR-AQ, participants at each severity level on average
made an improvement in their scores.
Figure 2. Frequency data of session number included in the sample.
Figure 3. Recovery trend on the WABR-AQ based on baseline severity.
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Dose form
Table 6 provides a summary of the number of therapy tasks completed
within the sessions shown in the videos according to each therapeutic group
within the trial. A list of all tasks completed in each condition is provided in
Appendix A (Usual Care-Plus) and Appendix B (VERSE).
Session duration
Table 7 provides a summary of session time to provide a context for the
measures reported in the results section.
Dose – all measured ingredients
Session dosage by therapy group
The dose of all client acts is presented in Table 8 as per the different therapy arms
in the trial and the group as a whole. The dose of all therapist inputs is presented
in Table 9. The groups were not found to be significantly different on any of the
measures, using Welch’s t-test for unequal variances with p > 0.001 (as per Bon-
ferroni correction) indicating an equivalent dosage across the different types of
intensive treatment.
Session dosage by aphasia severity
Dosage (client acts and therapist inputs) are outlined in Tables 10 and 11 respect-
ively according to aphasia severity at baseline. Significant differences were found
between the mild and moderate aphasia severity groups on the measures of per-
centage of errors self-corrected and mean length of utterance (words and mor-
phemes). Significant differences between the mild and severe severity group
were seen in measures of spontaneous verbal utterances, non-verbal responses,
self-corrections, percentage of errors self-corrected, mean length of utterance
Table 6. Tasks completed in therapy videos.
Measure




Usual Care – Plus (n =
25)
Total number of tasks across all sessions 152 56 96
Total number of different tasks across all
session
69 18 51
Average no. tasks per session 2.9 2 3.8
Total number of verbal tasks (%) 113 (74%) 48 (85%) 65 (68%)
Total verbal tasks at single word level (%) 53 (47%) 13 (27%) 40 (61%)
Total verbal tasks at sentence level (%) 43 (38%) 23 (48%) 20 (31%)
Total verbal tasks at conversation level (%) 17 (15%) 12 (25%) 5 (8%)
Table 7. Session duration in minutes.
Whole Group (n=53) Usual Care-Plus (n = 25) VERSE (n=28)
Mean Session Time (minutes) 51.9 (7.3) 50.9 (7.8) 52.8 (6.9)
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Table 8. Dosage (Client Acts) Descriptive Statistics.
Measure Whole Group (n = 53) Usual Care - Plus (n = 25) VERSE (n = 28)
Error free utterances*
Mean (SD) 307.4 (136.2) 302.5 (139.6) 311.8 (135.5)
Median (IQR) 289.0 (220.0) 292.0 (186.0) 273.0 (225.0)
Errors*
Mean (SD) 228.3 (134.7) 211.9 (135.7) 242.9 (134.6)
Median (IQR) 203.0 (155.0) 202.0 (189.0) 211.5(194.0)
Spontaneous verbal utterances*
Mean (SD) 253.5 (152.1) 257.3 (144.5) 250.0 (161.0)
Median (IQR) 215.0 (220.0) 267.0 (167.0) 214.5(287.0)
Non-verbal responses*
Mean (SD) 23.3 (45.0) 17.4 28.6
Median (IQR) 3.0 (18.0) 2.0 (17.0) 6.0 (19.0)
Self-Corrections*
Mean (SD) 36.3 (50.3) 22.0 (22.0) 49.2 (64.0)
Median (IQR) 18.0 (43.0) 13.0 (36.0) 24.5 (79.0)
% errors self-corrected
Mean (SD) 15.2 (16.5) 12.6 (14.4) 17.6 (18.1)
Median (IQR) 11.6 (20.6) 6.9 (16.3) 13.1 (26.9)
MLU (words)
Mean (SD) 3.2 (1.7) 2.9 (1.4) 3.5 (2.1)
Median (IQR) 3.0 (2.8) 2.8 (1.8) 3.4 (3.8)
MLU (morphemes)
Mean (SD) 3.6 (2.0) 3.2 (1.5) 3.9 (2.3)
Median (IQR) 3.3 (3.1) 3.1 (2.1) 3.7 (4.3)
Total turns*
Mean (SD) 506 (186.6) 500.8 (206.9) 510.7 (170.3)
Median (IQR) 510.0 (232.0) 485.0 (254.0) 520.5 (257.0)
Total Verbal Utterances*
Mean (SD) 478.5 (217.0) 483.4 (225.1) 474.2 (213.7)
Median (IQR) 495.0 (265.0) 477.0 (252.0) 509.0 (317.0)
Average errors per utterance
Mean (SD) 0.5 (0.2) 0.4 (0.2) 0.5 (0.3)
Median (IQR) 0.4 (0.2) 0.4 (0.2) 0.4 (0.4)
Average utterances per error
Mean (SD) 2.6 (1.3) 2.8 (1.3) 2.4 (1.3)
Median (IQR) 2.3 (1.3) 2.4 (1.3) 2.3 (1.5)
Total words*
Mean (SD) 1689.0 (1313.1) 1511.6 (1128.2) 1847.4 (1460.7)
Median (IQR) 1443.0 (1552) 1256.0 (1171.0) 1791.5 (2138)
% total words with errors
Mean (SD) 28.3 (41.7) 22.5 (25.5) 33.5 (52.1)
Median (IQR) 16.5 (21.5) 15.4 (19.2) 18.4 (27.7)
Sentence Level Errors*
Mean (SD) 23.9 (30.3) 23.4 (34.0) 24.3 (27.2)
Median (IQR) 13.00 (32) 11.0 (39) 20.0 (31)
Word Level Errors*
Mean (SD) 230.0 (160.6) 227.4 (162.3) 232.4 (162.0)
Median (IQR) 200 (214) 249.0 (238) 182 (202)
UPMa
Mean (SD) 9.7 (3.3) 9.8 (3.6) 9.7 (3.1)
Median (IQR) 9.3 (4.9) 9.5 (6.0) 9.2 (4.0)
WMPb
Mean (SD) 32.8 (24.2) 29.5 (19.8) 35.7 (27.7)
Median (IQR) 29.5 (28.3) 29.4 (27.2) 33.7 (51.5)
Mean turn length (words)
Mean (SD) 5.7 (5.1) 4.8 (3.5) 6.5 (6.2)
Median (IQR) 4.0 (7.0) 4.0 (4.3) 4.6 (9.3)
Note: * These measures were standardized according to session length. Descriptive statistics are presented in their




(words and morphemes), total words, percentage of total words with errors,
words per minute, mean turn length (words), cues used with success, total
number of cues used and total therapist utterances. Significant differences
between the moderate and severe severity groups were seen in measures of
spontaneous verbal utterances, non-verbal responses, percentage of errors
self-corrected, mean length of utterance (words and morphemes), total verbal
utterances, total words, percentage of total words with errors, utterances per
minute, words per minute, mean turn length (words). The direction of the signifi-
cance can be seen in the means provided. All other variables did not meet
Table 9. Dosage (Therapist Inputs) Descriptive Statistics.
Measure Whole Group (n = 53) Usual Care – Plus (n = 25) VERSE (n = 28)
Cues used with success*
Mean (SD) 33.8 (38.6) 38.5 (48.5) 29.6 (27.4)
Median (IQR) 18.0 (50) 15.0 (70) 19.5 (49)
Total number of cues used*
Mean (SD) 81.7 (72.9) 86.6 (74.8) 77.3 (72.3)
Median (IQR) 52.0 (110) 71.0 (112) 46.0 (110)
% Cues that were successful
Mean (SD) 39.9 (23.4) 38.2 (26.9) 41.5 (20.0)
Median (IQR) 40.4 (31.2) 33.3 (43.9) 40.8 (25.2)
Total therapist utterances*
Mean (SD) 675.1 (252.5) 679.6 (226.0) 671.1 (278.1)
Median (IQR) 642.0 (403) 656.0 (309) 639.5 (472)
Note: *These measures were standardized according to session length. Descriptive statistics are presented in their
raw score to maintain context.
aUtterances per minute.
bWords per minute.
Table 10. Dosage (client acts) descriptive statistics, (mean (SD)) and group comparisons by
aphasia severity.
Measure Mild (n = 16) Moderate (n = 17) Severe (n = 20) ANOVA p-value
Error free utterances* 340 (149.4) 354.3 (125.3) 241.5 (111.7) .045
Errors* 223.2 (152.9) 292.4 (147.0) 177.8 (81.4) .086
Spontaneous verbal* 318.6 (139.8) 329.8 (136.9) 136.5 (94.3) .000b,c
Non-verbal responses* 4.7 (7.3) 2.8 (3.5) 55.7 (61.1) .000b,c
Self-Corrections* 68.2 (70.1) 40.5 (37.4) 7.4 (11.2) .001b
% errors self-corrected 30.8 (18.7) 14.0 (10.7) 3.9 (5.6) .000a,b,c
MLU (words) 4.7 (1.4) 3.5 (1.3) 1.8 (1.2) .000a,b,c
MLU (morphemes) 5.2 (1.6) 3.9 (1.5) 2.0 (1.4) .000a,b,c
Total Verbal Utterances* 503.9 (1.8) 604.5 (171.2) 351.1 (207.6) .023c
Average errors per utterance 0.5 (0.4) 0.5 (0.2) 0.5 (0.2) .988
Average utterances per error 3.0 (1.8) 2.4 (0.9) 2.4 (1.0) .242
Total words* 2442.5 (1153.5) 2208.1 (1335.1) 645.0 (548.4) .000b,c
% total words with errors 9.6 (6.4) 15.8 (8.8) 53.8 (59.5) .001b,c
Sentence level errors* 25.8 (22.7) 34.4 (43.1) 13.5 (18.3) .158
Word level errors* 223.9 (180.5) 310.1 (168.3) 167.0 (105.1) .057
UPM 9.8 (3.2) 11.3 (2.7) 8.4 (3.5) .023 c
WMP 47.2 (20.0) 42.0 (24.3) 13.4 (12.2) .000b,c
Mean turn length (words) 9.3 (4.6) 6.5 (5.0) 2.2 (3.1) .000b,c
Note: MLU =Mean length of utterance. UMP = Utterances per minute. WPM =Words per minute.
*These measures were standardized according to session length. Descriptive statistics are presented in their raw
score to maintain context.
aSignificant difference between the mild and moderate groups.
bSignificant difference between mild and severe groups.
cSignificant difference between the moderate and severe groups.
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significance in post hoc testing p > 0.05. For full statistical sentences of each of
the post hoc analyses please see Appendix C.
Dose – active ingredients
Table 12 shows the linear regression of within session dosage measures and the
WABR-AQ score at 12 weeks post stroke. A Bonferroni correction was set for mul-
tiple comparisons (0.05 / 18measures) at p < 0.00277 and nomeasures met these
criteria for 12 weeks post stroke. Measures that were significantly predictive with
the WABR-AQ score at 26 weeks post stroke, as per Table 13 were: total verbal
utterances, percentage of total words with errors and the number of cues
used with success. These were hypothesized as key therapeutic ingredients in
the treatment and used in the cumulative intervention intensity calculation.
Table 11. Dosage (therapist inputs) descriptive statistics (mean (SD)) comparisons by aphasia
severity.
Measure Mild (n = 16) Moderate (n = 17) Severe (n = 20) ANOVA p-value
Cues used with success* 9.6 (8.5) 37.5 (35.7) 50.1 (46.7) .004a
Total number of cues used* 29.9 (31.6) 91.8 (69.6) 114.5 (78.8) .001a
% Cues that are successful 38.5 (26.8) 41.9 (22.7) 39.5 (22.1) .914
Total therapist utterances* 506.1 (188.6) 696.4 (260.6) 792.4 (224.2) .000a
Note: *These measures were standardized according to session length. Descriptive statistics are presented in their
raw score to maintain context.
aSignificant difference between mild and severe groups.
















1.947 0.911 .194 2.138 0.038
Total Errors* 0.815 0.97 0.077 0.84 0.405
Spontaneous verbal
utterances*
2.133 0.953 0.232 2.238 0.030
Self-corrections* 0.744 2.716 0.028 0.274 0.785
% Errors self-corrected 0.108 0.198 0.069 0.546 0.588
MLU (words) 1.94 1.901 0.134 1.021 0.313
Total Turns taken* 1.437 0.664 0.191 2.165 0.036
Total Verbal Utterances* 1.502 5.72 0.235 2.627 0.012
Average errors per
utterance
−6.23 9.514 0.060 −0.655 0.516
Average utterances per
error
−1.609 1.84 −0.081 −0.874 0.386
Total words* 0.164 0.126 0.150 1.305 0.198
Sentence level errors* 4.153 4.216 0.090 0.985 0.33
Word level errors* 0.708 0.763 0.085 0.928 0.358
% Total words with
errors
−0.139 0.062 −0.231 −2.22 0.031
Utterances per minute 1.455 0.668 0.192 2.179 0.034
Words per minute 0.167 0.121 0.157 1.387 0.172
Mean Turn Length 0.576 0.572 0.115 1.007 0.319
Cues used with success* 7.274 3.115 0.219 2.335 0.024
Note: * denotes variables were adjusted for length of session time.
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Cumulative intervention intensity
The dosage measures that were predictive of WABR-AQ score at 26 weeks
post stroke were considered to be key therapeutic ingredients for this treat-
ment and population. Measures that were predictive of patient response at
26 weeks post stroke were total verbal utterances, percentage of total
words with errors and cues used with success. Specifically the greater the
number of total verbal utterances that were produced per session (irrespective
of errors), the better the WABR-AQ score was at 26 weeks. The percentage of
total words with errors in the session was negatively associated with WABR-
AQ score meaning that the lower the percentage of words with errors in
the session, the higher the WABR-AQ score. Cues used with success was posi-
tively associated, with WABR-AQ at 26 weeks post stroke. The percentage of
total words with errors measure was a percentage calculation [(errors) /
(total words) × 100] and so the mean value is not representative of the
number of times the ingredient occurred during the session rather a
percentage of two other measures. As such it was problematic to use in
the intensity calculation and not selected. Therefore, total verbal utterances
and cues used with success were selected as the key therapeutic ingredients
in these treatments to use in the calculation of cumulative intervention
intensity.
Figure 4 presents the cumulative intervention intensity for both therapy
groups as per the sample used in this analysis. This figure is adapted from
Baker (2012) which was based on Warren et al. (2007) dosage concepts. When
considering the number of verbal utterances produced and the number of
cues used with success per session, people in the Usual Care-Plus group
Table 13. Linear regression of dose (client acts and therapist inputs) with patient outcome at 26
weeks post stroke.
Measure B SE B β t p
Total error free utterances* 2.332 0.934 0.249 2.498 0.016
Total Errors* 1.603 0.962 0.166 1.666 0.103
Spontaneous verbal utterances* 2.334 0.994 0.268 2.347 0.023
Self-Corrections* 1.006 2.809 0.042 0.358 0.722
% Errors self-corrected 0.053 0.205 0.037 0.26 0.796
MLU (words) 2.534 1.961 0.188 1.292 0.203
Total Turns taken* 1.937 0.687 0.268 2.82 0.007
Total Verbal Utterances* 2.077 0.577 0.337 3.598 0.001a
Average errors per utterance −2.989 −0.031 −0.031 −0.301 0.765
Average utterances per error −3.075 1.874 −0.170 −1.641 0.108
Total words* 0.213 0.13 0.205 1.637 0.109
Sentence level errors* 5.024 4.381 0.118 1.147 0.258
Word level errors* 1.31 0.783 0.168 1.673 0.101
% Total words with errors −0.21 0.06 −0.381 −3.479 0.001a
Utterances per minute 1.961 0.691 0.270 2.837 0.007
Words per minute 0.213 0.125 0.212 1.707 0.095
Mean Turn Length 0.637 0.592 0.137 1.076 0.288
Cues used with success* 10.82 3.039 0.355 3.561 0.001a
Note: *denotes variables were adjusted for length of session time.
adenotes significance after Bonferroni correction at p < 0.00277.
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averaged 522 active ingredient episodes each session with five sessions/ week
taking place over four weeks. This resulted in an average cumulative intervention
intensity of 10,400 during the trial. For individuals in the VERSE arm of the trial an
average of 504 active ingredient episodes occurred each session over five ses-
sions/ week for four weeks to give a cumulative intervention intensity of
10,080 during the trial.
Figure 4. Calculation of cumulative intervention intensity as per Warren et al. (2007) concepts.
Numbers presented in parentheses are the mean values from the sample.
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Discussion
This study aimed to provide insight into the dosage level provided within the
intensive intervention arms of the VERSE trial (Godecke et al., 2016). Specifically,
we have provided (i) normative dosage data across the intervention groups and
aphasia severities; (ii) an exploration of potential key therapeutic ingredients to
explain recovery in this population; and (iii) a specification of the intervention
according to the dosage and intensity theory of Warren et al. (2007). Our goal
was not to provide a therapy regimen for therapists to follow. Rather, we
aimed to develop an increased understanding of the key ingredients of the
therapy provided in the VERSE trial and the dosage with which theorized ingre-
dients were provided. In doing so we have trialled a method of identifying
potential active ingredients and measuring dosage for this population. We
hope to stimulate further discussion and encourage the research agenda in
the area in order to improve the methodology used within intervention
studies when considering the way in which therapies are delivered. In the
long term this will assist in uncovering the elements of treatment that are
most likely to improve functional outcomes and the dosage with which these
elements, or ingredients, are delivered.
The therapy black box
On average, the participants within this study, who were from three aphasia
severity groups, made a clinically significant improvement in their recovery
from aphasia as measured by the WABR-AQ (Kertesz, 2006). Turkstra et al.
(2016) proposed that any treatment be specified using three elements of treat-
ment theory: (i) targets, (ii) ingredients and (iii) mechanisms of action. These
elements of treatment theory are likely to make up the as yet unknown “black
box” of aphasia interventions (DeJong et al., 2005; Walker et al., 2017). The
main contribution of these results is to the ingredients element of treatment
theory (Turkstra et al., 2016). Whilst no single piece of research can establish
what, how and how much to do in therapy, we trialled a method of identifying
key ingredients for therapy provided within the VERSE trial and measured the
dosage with which significant ingredients occurred. Within this study three
measures were identified that were associated with language outcome at 26
weeks post stroke. These were increased verbal utterances (client act),
reduced percentage of words produced which contained errors (client act)
and increased cues used with success (likely represents both a client act and
therapeutic input). Interestingly these measures represented both therapeutic
inputs and client acts (Kleim & Jones, 2008) in Baker’s (2012) model and may
be the evidence based kernels or the active ingredients of the treatment
within this intervention trial (Embry & Biglan, 2008). While the model shown in
Figure 5 is focused on the teaching episodes within tasks it is acknowledged
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that there are many other components of the rehabilitation jigsaw that contrib-
ute to therapeutic success, in conjunction with the teaching episode, and a few
are listed here.
The results presented here support an error minimization (not error-free)
approach possible through a targeted cueing programme that aims to create suc-
cessful verbal production. This is balanced with encouraging the person with
aphasia to say asmuch as possible and to provide clinical support to facilitate pro-
duction which contains as few errors as possible. It should be highlighted that
intervention provided in the VERSE trial was provided during early aphasia recov-
ery and so it is unknown if thesefindingswouldbe similar for people in the chronic
phase of recovery. Within this study a novel approach was used to determine key
therapeutic ingredients of the treatment in an attempt to explore how therapeutic
ingredientsmay be identified. A regressionmodel was usedwith theWABR-AQ as
the dependent variable and while this approach found predictions with three
dosagemeasures, caution is needed with interpretation. Measures that were pre-
dictive (specifically verbal utterances and reduced percentage of words with
errors) may logically be related to the WABR-AQ score. That is, a person with
aphasia who produces more utterances and less errors will have a better score
on the WABR which is by design a predominantly verbal accuracy test.
However, of note, is that the measures were taken within the first month post
stroke, and were predictive at six months and baseline aphasia severity and
amount of intervention received was included in the model. This has provided
an attempt at identifying how the handling of errors, or other potential key ingre-
dients such as cueing, affected target attainment more generally (Turkstra et al.,
2016). This predictive relationship was observed from a snapshot of therapy ses-
sions that involved sixty nine different therapy tasks in early aphasia recovery.
Figure 5. Adapted from Baker (2012), the relationship between dose form, teaching episodes
and active ingredients.
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This figure is adapted from Baker (2012) and explores the relationship
between key components of dosage and speech language pathology interven-
tions. The puzzle piece represents other elements of rehabilitation that may con-
tribute to therapeutic success.
Literature outlining complex treatments often lack information regarding
specific active ingredients and their corresponding dosage. This is largely due
to difficulty investigating these complex behavioural interventions and the
impact of a myriad of factors including therapeutic relationship, environment
and client motivation (Cherney, 2012). We used a formula presented by
Warren et al. (2007) to calculate the dosage and cumulative intervention inten-
sity for a sample of therapy delivered in the VERSE trial. Identifying the key thera-
peutic ingredients was challenging especially as tasks were not controlled and
retrospective data were used. Potential ingredients were identified in the
design phase that linked to the theory underpinning the interventions. That is,
the measurement and handling of errors was thought to be key to neurorehabil-
itative learning and aphasia therapy and so prioritized. Then in an exploratory
manner these key ingredients were counted and coded in the analysis phase
however we acknowledge that the active ingredients measured here do not rep-
resent all possible key ingredients. The level of analysis undertaken in this study
was time consuming however it provides a framework for this line of inquiry to
develop further. We suggest focusing on the theory behind the intervention to
measure targeted ingredients only in a prospective manner. That is, measure a
small number of ingredients thoroughly with the aim to draw conclusions
about their role in therapy, whilst embedding a larger rigorous fidelity monitor-
ing process to establish treatment adherence and differentiation. The detailed
analysis of active ingredients should be included in all smaller pilot studies
with an aim to discover which ingredients are positively associated with
outcome. These intervention kernels should then be tested on a larger sample
in feasibility and Phase-III studies.
Critical variables for aphasia therapy are thought to include the intensity and
dosage, therapeutic relationship, medium of therapy delivery, client motivation
to engage, cognitive ability and neurological stability (Whitworth et al., 2014) and
the active ingredients that promote an individual’s recovery may lie within these
variables. There is also the possibility that the active ingredients of therapy are
not directly observable or so readily measurable. The concept of activity chal-
lenge and the level of task difficulty is a parameter in stroke rehabilitation that
is receiving increasing attention and will influence the outcome of future
study designs (Akizuki & Ohashi, 2015; Woodbury et al., 2016). Therefore, not
only should the quantity of therapeutic inputs and client acts be addressed
but also the quality of these, such as a measure of task difficulty relative to
the individual, with an optimal challenge point identified (Guadagnoli & Lee,
2004). An alternative but related view of therapy could be gained through quali-
tative analysis and/or systemic function linguistic analysis (O’Halloran, 2004) of
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therapy videos. This could investigate more thoroughly aspects of the thera-
peutic relationship such as rapport and patient comfort levels. It is acknowl-
edged that an in-depth analysis was not completed to explore the nature of
interactions between the therapists and people with aphasia. This was not the
aim of the work, however such an undertaking is likely to capture a richness
of therapy not represented in the quantitative data set.
Dosage
The optimal treatment dosage in aphasia rehabilitation is unknown with signifi-
cantly more research required (Baker, 2012; Dignam et al., 2015; Off et al., 2016).
For this study the cumulative intervention intensity is over 10,000 occurrences of
the ingredients predictive of recovery within an intervention block of twenty ses-
sions. This means that, on average, approximately 500 of these key ingredients
were delivered and received each session. The VERSE trial’s primary hypothesis
investigated an intensive therapy schedule which demonstrated equivalent out-
comes between intensive therapy and standard care in early stroke recovery
(Godecke et al., 2018). It should be highlighted that only data from the intensive
intervention arms of the trial were included in this study, videos from therapy
provided within non intensive usual care were not included and so we don’t
know the findings from therapy that may be delivered at a lower dose. It may
be that the within session dosage level that was delivered is necessary but not
on an intensive schedule. In the overall trial cohort sessions of longer duration
were associated with better recovery than a larger number of shorter sessions
(Rai et al., 2019). Sessions of longer duration may result in an increased
dosage of the key client acts and therapist inputs. Based on VERSE efficacy
data, positive therapeutic results may be achieved with less frequent sessions
but this level of within session dosage. Alternatively, it may be that the
dosage level provided in the VERSE trial is not necessary and participants were
“overdosed”. A further alternative is that the dosage provided to the participants
in the VERSE trial, and in this study, was insufficient to show benefit in communi-
cation and language. Harnish et al. (2014) measured the dosage of active ingre-
dients in a cueing treatment for people with chronic aphasia and found positive
outcomes with 400 attempts per session for a total of 3200 teaching episodes.
Therefore, future studies may aim to determine a threshold at which these
potential active ingredients are associated with a positive outcome within a
session in order to inform research consumers about what was delivered in
the trial and assist research translation.
This study outlines the findings of a detailed analysis of the intervention
dosage provided within the VERSE study however, while the length of the ses-
sions was set, a minimum target for repetitions was not set in either the pre-
scribed or Usual Care-Plus conditions. We have provided an analysis of a
“typical” 45–60 min aphasia therapy session using usual care data, possibly
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providing a benchmark to be used as normative data in the future. Usual Care-
Plus therapists were not given a prescribed therapy. Therefore, we believe that
the results presented here are representative of therapy provision within Austra-
lia and the dosage level seen within a sessions of this length. This, combined with
the information from the main trial (usual care was two to three times per week
for 30–36 min or 9.5 h of direct aphasia therapy within the first 50 days post
stroke), provides an unprecedented level of information on usual care aphasia
therapy within Australia and New Zealand. It is interesting to note that there
was not treatment differentiation for dosage between the prescribed interven-
tion (VERSE) and Usual Care-Plus on the analyses completed as part of the
current study. And so, even when a treatment was prescribed to the therapists,
the measures examined in this study did not differ significantly. This may be
because Usual Care-Plus therapists were using the same principles as the pre-
scribed therapy, or that there is a homogeneity in the way that PWA respond
to tasks.
There were statistically significant differences in the measured dosage vari-
ables across aphasia severities as expected. This demonstrated that classification
of severity at baseline remained relevant to the performance of PWA during
therapy sessions within the subsequent month. Of note, people with severe
aphasia had significantly less spontaneous verbal utterances, percentage of
errors self-corrected and words spoken compared to people with mild and mod-
erate aphasia. They were consistently lower on verbal efficiency measures such
as utterances per minute, words per minute and mean length of utterance. As
this fits the common picture of aphasia severity it may also be expected that
they would make more mistakes in a session. People with moderate aphasia pro-
duced the most errors (total errors) but also more utterances without errors and
more total verbal utterances than people with severe aphasia. This may reflect a
trade-off of attempting to say more but making more errors in the process. As a
proportion of the total words produced people with severe aphasia made errors
over 50% of the time. This was consistent even in the prescribed VERSE condition
that aimed for an error free approach. Even when aiming for an errorless or error
minimization learning approach with someone with severe aphasia, therapists
may not be able to restrict errors to less than 50% of words produced. It is poss-
ible that regardless of the therapists’ attempts to limit errors, there is a predict-
ability and a homogeneity to the way PWA respond in a task. People with mild
aphasia produced more self-corrections and were able to produce more words
across less utterances reflected in a higher MLU. As expected, many of the par-
ticipants with mild aphasia at baseline approached ceiling level on the WAB-AQ
by 12 and 26 weeks post stroke.
These findings encourage researchers to undertake fine-grained dosage
(number of therapeutic inputs and client acts) analyses of their research in
both intervention and control groups. The analyses completed here demonstrate
that this is feasible within a portion of the RCT cohort. By nature, retrospective
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analysis of a cohort such as completed here is unable to systematically identify
and vary dosage variables. Prospective hypothesis driven studies that manip-
ulate ingredients and dose may facilitate a clearer interpretation. The ingredients
identified in this study would benefit from planned experimental investigations
to test the robustness of the interpretations. Dose escalation study designs are
being adapted for rehabilitation research and present one possible future direc-
tion for aphasia (Kramer et al., 2018). Additionally, future research would benefit
from focusing on conceptualizing dosage in terms of number of key ingredients
(therapeutic inputs and client acts), rather than time spent in therapy, to pro-
gress the evidence base. Research needs to document dosage in this way for
treatments given in trials, however specific research in which dosage is varied
within a treatment is also needed (Kramer et al., 2018). It would be of value
for RCT pilot studies to conceptualize potential active ingredients in the trial
design phase, measure these against outcomes, fine tune the procedure and
then scale up to the larger trial.
Clinical significance
Investigating dosage in aphasia research is important in the clinical realm. An
inaccurate dose may be a waste of precious resources, harmful, ineffective or
equivalent to no intervention (Baker, 2012). Treatments are implemented in prac-
tice that combine several different forms and doses of intervention and typically
this combination is untested and the implementation may be in direct contrast
to how they were evaluated (O’Hare & Doell, 2015; Waller, 2009). These are called
“third wave therapies” and they may not provide the required dosage of therapy
to be effective (Waller, 2009). In addition, the dosage level decided on by a thera-
pist may be influenced by all areas of the evidence based practice triad, including
patient values and clinical expertise (Sackett et al., 1996). If researchers can
provide clinicians with the evidence of a threshold dose for a treatment then
therapists can more accurately manipulate treatments according to clinical
results and patient related factors. If a specific dose can be determined then ser-
vices can be utilized at their optimum level and resources can be reallocated
where necessary.
Limitations
This study aimed to explore dosage, as provided in the VERSE study, and trialled
a method for analysing the therapy provided. It was a novel approach and
although the findings give an important insight into therapeutic dosage, the
method for identifying key ingredients should be interpreted with caution. A
reductive interpretation of the methodology used in this study would be that
measures that were predictive of outcome may logically be related to the
WABR-AQ score. That is, a person with aphasia who produces more utterances
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and less errors in therapy will have a better score on the WABR-AQ which is by
design a predominantly verbal accuracy test. The study was retrospective and
therefore dosage variables at the ingredients level were not able to be controlled
or manipulated. This study design adds complexity to the relationship interpret-
ation. The values used in the cumulative intervention intensity model are
averages attained in the analysis. The drawbacks of using average scores as a
measure is acknowledged. The WAB-R is predominantly a verbal accuracy test.
Other modalities for the outcome measure such as written expression or recep-
tive language were not considered in the scope of this work. This study analysed
12% of the available videos in the VERSE trial. This represents a small sample and
so there is a limit to the extrapolation of these results to represent the dosage
within the trial as a whole. Additionally this means the current study may have
been underpowered. The primary rater for the videos was not blinded to the
treatment condition as unblinding was necessary for monitoring protocol adher-
ence and treatments were also easily distinguishable based on task selection and
the potential for bias exists.
Conclusion
This study demonstrated it is feasible to analyse the dosage of therapy in aphasia
rehabilitation. Overall, these results suggest that an error minimization but verbal
maximization strategy using a targeted cueing programme is beneficial for
people with aphasia in the early stroke recovery period. There is, of course,
great difficulty in determining what our therapy consists of and the way in
which this acts on the brain to facilitate recovery. Regardless of the intensity
regimen, we have demonstrated that this cumulative intervention intensity
and within session level dosage contributes to positive outcomes for people
with aphasia in early stroke recovery.
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Appendices
Appendix A. Tasks completed in usual care-plus condition
Type of Task, in order of most to least frequent (n = 51) Quantity (n = 96)
Expressive Language – Verbal
Single Word Level
Picture Naming 12
Semantic association naming 5
Automatic Speech 4
Odd one out (semantic) 3
Naming minimal Pairs 2
Object naming 2
Question and Answer task 2
(Continued )
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Continued.





Repetition of non-words 1
Phonemic Generative Naming 1
Semantic Category identification 1
Single word repetition 1
Sentence Level
Picture description (not personal photo) 5
Constraint Induced Aphasia Therapy (CIAT) style barrier game 3
Reading aloud 3
Verbal reasoning (idioms and problem solving) 2
Articulate game (verbal explanation) 1
Personal photo description 1
Procedural discourse (e.g., making a cup of tea) 1
Reading semantic feature analysis prompts for to generate words 1
Script training 1
Solitaire card game (verbal requests) 1
Taboo (verbal explanation) 1
Conversation Level
Conversation 4
Situational Language (e.g., ordering a coffee) 1
Expressive Language – Written
Single Word Level
List writing (self-generated words) 2
Single word writing (from dictation) 2
Crosswords 1
Functional writing (name, address etc.) 1
Hangman game (letter and word generation) 1
Sentence Level
Written work sheet for sentence composition 2
Writing answers to reading comprehension 1
Written picture description 1
Receptive – Reading Comprehension
Paragraph Comprehension (answering questions) 2
Receptive – Auditory Comprehension
Single Word Level
Object to picture matching 2
Picture matching (same picture to same picture) 1
Semantic association receptive task (match associated pictures) 1
Semantic association (which one can you eat?) 1
Single word auditory comprehension 1
Sentence Level
Semantic description comprehension task 2
Following a receptive command to place a picture in a grid 1
Paragraph level
Newspaper article with multiple choice questions 1
Paragraph comprehension (listening for the main idea) 1
Yes/No Questions after listening to a paragraph 1
Other – iPad Tasks
iPad written single word to picture matching 2
iPad articulation app 1
iPad choosing the missing letter 1
iPad sorting jumbled letters 1
iPad verbal single word to picture matching 1
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Appendix B. Tasks completed in VERSE condition
Type of Task (n = 18) Quantity (n = 56)
Expressive Language – Verbal
Single Word Level
Picture Naming 10
Memory Game with naming 1







Sequence picture cards and asked to tell the story 4
Question and Answer 2
Spot the difference 1
Verb generation sentence level 1




Receptive – Reading Comprehension
Paragraph Comprehension 3
Receptive – Auditory Comprehension
Single Word Level
Point to the picture multiple choice 4
Above Single Word Level
Sentence Comprehension 1
Appendix C
The effect of severity on spontaneous verbal utterances was significant F (2,50) = 13.87, p =
000. Post hoc analyses indicated that the number of spontaneous verbal utterances was sig-
nificantly higher in the mild to severe (p = 0.000) and moderate to severe (p = 0.000) groups.
The effect of severity on non-verbal utterances was significant F (2,50) = 11.541, p = 000 and
significantly higher in the severe compared to mild group (p = 0.001) and the moderate to
severe (p = 0.000) group. The number of self-corrections was significantly affected by
aphasia severity F (2,50) = 8.762, p = 001. Post hoc analysis indicated that the number of
self-corrections was significantly greater in the mild compared to severe group (p = 0.000).
Percent of errors self-corrected was significantly affected by aphasia severity F (2,50) =
21.137, p = 000. Post hoc analyses indicated that the mild group had a significantly higher per-
centage of self-corrections compared to the moderate (p = 0.001) and severe groups (p =
0.000) and the moderate group had a significantly higher percentage of self-corrections com-
pared to the severe group (p = 0.050). The effect of aphasia severity on mean length of utter-
ance (words) was significant F (2,50) = 22.619, p = 000. Post hoc analyses indicated that the
mild group had a significantly higher mean length of utterance compared to the moderate
(p = 0.034) and severe groups (p = 0.000) and the moderate group had a significantly
higher mean length of utterance compared to the severe group (p = 0.001). The effect of
aphasia severity on mean length of utterance (morphemes) was significant F (2,50) =
21.649, p = 000. Post hoc analyses after Bonferroni correction indicated that the mild group
had a significantly higher mean length of utterances (morphemes) compared to the moderate
(p = 0.043) and severe groups (p = 0.000) and the moderate group had a significantly higher
mean length of utterance (morphemes) compared to the severe group (p = 0.001). Aphasia
severity significantly affected the number of total utterances in a session F (2,50) = 4.051, p
= .023. In post hoc analysis the severe group had significantly fewer total utterances than
the moderate severity group (p = 0.019). Aphasia severity significantly affected the number
of total words in a session F (2,50) = 17.695, p = .000. Post hoc analyses demonstrated that
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the number of total words in a session was significantly higher in the mild group compared to
the severe group (p = 0.000). And the moderate severity group said significantly more words
than the severe group (p = 0.000). Aphasia severity significantly affected the percent of total
words that had errors F (2,50) = 7.689, p = .001. Post hoc analyses indicated that the number of
total words with errors was significantly lower in themild group compared to the severe group
(p = 0.003). And the moderate severity group had significantly less percentage of total words
with errors compared to the severe group (p = 0.010). The effect of aphasia severity on utter-
ances per minute was significant F (2,50) = 4.053, p = 023 with the moderate severity group
having a significantly higher utterance per minute ratio than the severe group (p = 0.019).
The effect of aphasia severity on words per minute was significant F (2,50) = 16.825, p =
000. Post hoc analyses revealed that the mild severity group and the moderate severity
group had a significantly higher words per minute ratio compared to the severe group, (p
= 0.000) and (p=0.000) respectively. The effect of aphasia severity on mean turn length
(words) was significant F (2,50) = 12.063, p = 000. Post hoc analyses indicated that the mild
severity group and the moderate severity group had a significantly higher mean turn
length compared to the severe group (p = 0.000) and (p=0.008) respectively. Aphasia severity
significantly affected the number of cues used successfully in a session F (2,50) = 6.137, p
= .004, as significantly less cues were used with success in the mild compared to severe sever-
ity groups (p = 0.003). Aphasia severity significantly affected the number of total cues used F
(2,50) = 7.660, p = .001. Post hoc analyses indicated that significantly less cues were used in
total in the mild compared to severe severity groups (p = 0.001). The effect of aphasia severity
on the total utterances used by the therapist was significant F (2,50) = 11.086, p = 000. In a post
hoc analysis there were significantly less utterances by the therapist in the mild compared to
severe group (p = 0.000).
All other variables did not meet significance in post hoc testing p > 0.05.
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